UNSPSC 51422420: Desoxycortone pivalate

This classification denotes a therapeutic glucocorticoid with the molecular formula C26H38O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 16665T4A2X, chemically known as 21-(2,2-dimethyl-1-oxopropoxy)pregn-4-ene-3,20-dione but more generally known as desoxycorticosterone pivalate, which bears US NIH Compound Identifier 13126. European Medicines Agency schedules Desoxycortone pivalate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01603MIG.

Most nations, for tariff and trade purposes, schedule desoxycortone pivalate under HS 29372900. SMILES: C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)COC(=O)C(C)(C)C)CCC4=CC(=O)CC[C@]34C.

UNSPSC 51422420 Desoxycortone pivalate is a Commodity code with minimal alignment to actual state and local procurement activity in the recent opportunities block. The two recent solicitations tagged under this code—Seminole County's procurement of naloxone and drug deactivation systems, and the Texas Health and Human Services Commission's request for information on direct-to-manufacturer prescription programs—do not match the nominal scope of a specific steroid pharmaceutical. State and local governments are buying naloxone (an opioid antagonist) and establishing pharmacy benefit models under these solicitations, neither of which is desoxycortone pivalate. The code shows little relevant recent activity for the work actually being procured.

No further detail supports a meaningful business development assessment under this code. Vendors pursuing state and local pharmaceutical procurement should monitor codes tied to broader pharmacy benefit management, emergency medical supplies, or general pharmaceutical distribution rather than this specific commodity code.